Total trials
1,404
Active
226
Phase 3
50
Total enrollment
10,871,944
Pipeline matrix
Showing 7 of 7 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Red Blood Cell | — | — | — | — | — | 1 | |
| Lamotrigine | — | — | — | — | 2 | ||
| GLP-1 RAs | — | — | — | — | — | 1 | |
| Hematopoetic Stem Cell Transplantation | — | — | — | — | — | 1 | |
| Levetiracetam | — | — | — | — | — | 1 | |
| Oxcarbazepine | — | — | — | — | — | 1 | |
| Prucalopride 1 MG | — | — | — | — | — | 1 |
Next readouts
- 2026-07-31
- 2026-12-31
- 2027-04-01
- 2027-04-30
- 2030-01
Top conditions
- Depression74
- Obesity49
- Cardiovascular Diseases22
- Cancer20
- Anxiety20
- Sleep19
- Schizophrenia19
- Bipolar Disorder17
Frequently asked questions about University of Pittsburgh
- How many clinical trials does University of Pittsburgh have on ClinicalTrials.gov?
- University of Pittsburgh is listed as the lead sponsor on 1,404 clinical trials in ClinicalTrials.gov, 226 of which are currently active (recruiting, enrolling, or ongoing).
- How many of University of Pittsburgh's trials are in Phase 3?
- 50 of University of Pittsburgh's trials are in Phase 3, spread across 7 active drug programs.
- What therapeutic areas does University of Pittsburgh focus on?
- University of Pittsburgh's most-studied conditions on ClinicalTrials.gov are Depression, Obesity, Cardiovascular Diseases, Cancer, Anxiety.
- When are University of Pittsburgh's next clinical trial readouts?
- University of Pittsburgh has 5 upcoming primary-completion readouts tracked here; the soonest is “Sickle Cell Disease and CardiovAscular Risk - Red Cell Exchange Trial (SCD-CARRE)”, expected around 2026-07-31.